First Published Case of Alzheimer's Biomarker Reversal in a Chronic Lyme Disease Patient Using Dapsone Combination Therapy
PRNewsWire
·
2026-04-28
·
via The Tech Buzz - Press Releases
Peer-reviewed findings published in the Journal of Alzheimer's Disease Reports show a 63% reduction in phosphorylated tau after a nine-week oral protocol HYDE PARK, N.Y., April 27, 2026 /PRNewswire/ -
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。
